|Articles|August 1, 2004
Vaccine: multipeptide cocktail suits patients
New Orleans - Vaccination with a mixture of 12 peptides was immunogenic in 100 percent of melanoma patients tested, even with multiple peptides competing for the same cell surface binding sites, according to Craig L. Slingluff, Jr., M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
2
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
3
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
4
French Early Access Data on Dupilumab in Pediatric Atopic Dermatitis
5














